Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
Actinium-225 for targeted α therapy: coordination chemistry and current chelation approaches
The α-emitting radionuclide actinium-225 possesses nuclear properties that are highly
promising for use in targeted α therapy (TAT), a therapeutic strategy that employs α particle …
promising for use in targeted α therapy (TAT), a therapeutic strategy that employs α particle …
Carrier systems of radiopharmaceuticals and the application in cancer therapy
T Zhang, H Lei, X Chen, Z Dou, B Yu, W Su… - Cell Death …, 2024 - nature.com
Radiopharmaceuticals play a vital role in cancer therapy. The carrier of
radiopharmaceuticals can precisely locate and guide radionuclides to the target, where …
radiopharmaceuticals can precisely locate and guide radionuclides to the target, where …
Alpha-peptide receptor radionuclide therapy using actinium-225 labeled somatostatin receptor agonists and antagonists
Peptide receptor radionuclide therapy (PRRT) has over the last two decades emerged as a
very promising approach to treat neuroendocrine tumors (NETs) with rapidly expanding …
very promising approach to treat neuroendocrine tumors (NETs) with rapidly expanding …
Therapeutic radionuclides in nuclear medicine: current and future prospects
The potential use of radionuclides in therapy has been recognized for many decades. A
number of radionuclides, such as iodine-131 (131I), phosphorous-32 (32P), strontium-90 …
number of radionuclides, such as iodine-131 (131I), phosphorous-32 (32P), strontium-90 …